Can cosentyx be prescribed for children?

Can Cosentyx be prescribed for children?

Cosentyx is approved by the FDA for use in children aged 6 and older who have moderate to severe plaque psoriasis. It is also approved for children aged 2 and older who have juvenile psoriatic arthritis or enthesitis-related arthritis.

How does Cosentyx work in kids?

Cosentyx targets interleukin-17A, a cytokine involved in inflammation. It is given as a weekly injection for the first five weeks, then every four weeks. Dosing is based on body weight, so pediatric patients receive 75 mg or 150 mg doses depending on their body weight under 50 kg or 50 kg or more.

What are the clinical trial results for pediatric use?

Clinical trials showed that Cosentyx reached PASI 75 in 60-70% of children with plaque psoriasis at week 12, compared to 11-27% with placebo. It also achieved IGA 0/1 responses in 55-75% of children. In arthritis-related conditions, pain and swelling scores improved significantly after 12 weeks.

What risks do parents worry about?

Parents worry about infection risk, especially tuberculosis reactivation and inflammatory bowel disease worsening. Clinical data showed infections occurred at 20-25% of rate in children, but serious infections were rare. Parents also seek reassurance about long-term safety since Cosentyx is a biologic targeting the immune system.

When does Cosentyx's patent expire?

Cosentyx's patents expire in 2026, with some extended protection through regulatory exclusivity. [1]

When does Cosentyx come off patent?

Cosentyx's patents expire in 2026, with some extended protection through regulatory exclusivity. [1]

When does Cosentyx come off patent?

Cosentyx's patent protection ends in 2026. [1]

Duplicated sections eliminated.